Document is current

Any future updates will be listed below

Disproportionality analysis of Raynaud’s phenomenon associated with calcitonin gene-related peptide inhibitors using the Food and Drug Administration adverse event reporting system

Crossref DOI link: https://doi.org/10.1038/s41598-025-87421-w

Published Online: 2025-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark